.jpg)
2015 Spring CLU Highlights
ApoB in Risk Assessment and the Diagnosis and Treatment of the Atherogenic Dyslipoproteinemias
Allan D. Sniderman, MD
Allan D. Sniderman, MD presents his talk on ApoB in Risk Assessment and the Diagnosis and Treatment of the Atherogenic Dyslipoproteinemias.
Start Presentation Slides Audio OnlyTags:
Inflammation, Risk Prediction, and the Prevention of ASCVD
Paul M. Ridker, MD
Paul M. Ridker, MD presents his talk on Inflammation, Risk Prediction, and the Prevention of ASCVD.
Start Presentation Slides Audio OnlyTags:
Two Different Prevention Approaches Two Different Perspectives
Carl E. Orringer, MD, FNLA
Carl E. Orringer, MD, FNLA presents his talk on Two Different Prevention Approaches Two Different Perspectives.
Start Presentation Slides Audio OnlyTags:
Clinical Management of Hypertriglyceridemia: State of the Art 2015
Eliot A. Brinton, MD, FNLA
Eliot A. Brinton, MD, FNLA presents his talk on Clinical Management of Hypertriglyceridemia: State of the Art 2015.
Start Presentation Slides Audio OnlyTags: